Cargando…
A Binding Mode Hypothesis of Tiagabine Confirms Liothyronine Effect on γ-Aminobutyric Acid Transporter 1 (GAT1)
[Image: see text] Elevating GABA levels in the synaptic cleft by inhibiting its reuptake carrier GAT1 is an established approach for the treatment of CNS disorders like epilepsy. With the increasing availability of crystal structures of transmembrane transporters, structure-based approaches to eluci...
Autores principales: | Jurik, Andreas, Zdrazil, Barbara, Holy, Marion, Stockner, Thomas, Sitte, Harald H., Ecker, Gerhard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360375/ https://www.ncbi.nlm.nih.gov/pubmed/25679268 http://dx.doi.org/10.1021/jm5015428 |
Ejemplares similares
-
Insights into binding events of GABA- and Tiagabine- analogues in the Gamma-Aminobutyric Acid Transporter 1 by means of Molecular Modelling
por: Zdrazil, Barbara, et al.
Publicado: (2012) -
Pairwise structural comparison of tiagabine analogs gives new insights into their protein binding modes
por: Zdrazil, Barbara, et al.
Publicado: (2013) -
Classification of High-Activity Tiagabine Analogs by Binary QSAR Modeling
por: Jurik, Andreas, et al.
Publicado: (2013) -
Analysis of Different Binding Modes for Tiagabine within the GAT-1 Transporter
por: Łątka, Kamil, et al.
Publicado: (2022) -
Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1
por: Zafar, Sadia, et al.
Publicado: (2020)